These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26365142)

  • 1. GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System.
    Gazulla J; Ruiz-Gazulla C; Tintore M
    Curr Pharm Des; 2015; 21(34):4989-95. PubMed ID: 26365142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adult-onset ataxia-telangiectasia. A clinical and therapeutic observation].
    Gazulla J; Benavente I; Sarasa Barrio M
    Neurologia; 2006 Oct; 21(8):447-51. PubMed ID: 17013792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.
    Gazulla J; Errea JM; Benavente I; Tordesillas CJ
    Eur Neurol; 2004; 52(1):7-11. PubMed ID: 15218338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adult GM2 gangliosidosis: improvement of ataxia with GABAergic drugs].
    Gazulla Abío J; Benavente Aguilar I
    Neurologia; 2002 Mar; 17(3):157-61. PubMed ID: 11927106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An update on neurochemistry and pharmacological therapy of the cerebellar ataxias].
    Gazulla J
    Rev Neurol; 2007 Jul 1-15; 45(1):31-41. PubMed ID: 17620264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit.
    Gazulla J; Tintoré MA
    Med Hypotheses; 2007; 68(1):131-6. PubMed ID: 16899342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvements in the symptoms of olivopontocerebellar atrophy with gabapentin].
    Gazulla J; Benavente MI
    Rev Neurol; 2005 Mar 1-15; 40(5):285-8. PubMed ID: 15782360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications acting on the GABA system in the treatment of alcoholic patients.
    Caputo F; Bernardi M
    Curr Pharm Des; 2010; 16(19):2118-25. PubMed ID: 20482512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA Receptors: Pharmacological Potential and Pitfalls.
    Jembrek MJ; Vlainic J
    Curr Pharm Des; 2015; 21(34):4943-59. PubMed ID: 26365137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy.
    Gazulla J; Benavente I
    Acta Neurol Scand; 2007 Oct; 116(4):235-8. PubMed ID: 17824901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-modulation of acute ethanol-induced motor impairment by mouse cerebellar adenosinergic A1 and GABA(A) receptor systems.
    Saeed Dar M
    Brain Res Bull; 2006 Dec; 71(1-3):287-95. PubMed ID: 17113958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABAergic System and the Gastrointestinal Physiopathology.
    Auteri M; Zizzo MG; Serio R
    Curr Pharm Des; 2015; 21(34):4996-5016. PubMed ID: 26365138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate transporter EAAT4 in Purkinje cells controls intersynaptic diffusion of climbing fiber transmitter mediating inhibition of GABA release from interneurons.
    Satake S; Song SY; Konishi S; Imoto K
    Eur J Neurosci; 2010 Dec; 32(11):1843-53. PubMed ID: 21070388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
    Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
    Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valproic acid relieved marked rigidity in three patients with end-stage parkinsonism].
    Sayama S; Fujimoto K; Nakano I
    Rinsho Shinkeigaku; 1998 Jun; 38(6):495-8. PubMed ID: 9847665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and neurochemical aspects of diaphragmatic myoclonus].
    Gazulla Abío J; Feijóo de Freixo M; Val Adán P; Benavente Aguilar I
    Neurologia; 2003 Oct; 18(8):473-7. PubMed ID: 14615952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurochemical aspects of spinocerebellar degeneration].
    Kanazawa I
    Rinsho Shinkeigaku; 1993 Dec; 33(12):1288-90. PubMed ID: 7909729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.
    Mitoma H; Song SY; Ishida K; Yamakuni T; Kobayashi T; Mizusawa H
    J Neurol Sci; 2000 Apr; 175(1):40-4. PubMed ID: 10785255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging Applications in Chronic Ataxias.
    Mascalchi M; Vella A
    Int Rev Neurobiol; 2018; 143():109-162. PubMed ID: 30473193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.